Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Venetoclax with decitabine or azacitidine for AML.

× No keyword cloud information.

9 in total

1. A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cells.

Authors: Martin Grundy; Firas Al-Kaisi; Joanna Cull; Cathy Williams; Dean Smith; Claire H Seedhouse
Journal: EJHaem Date: 2020-11-20

Review 2. Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy.

Authors: Tianshu Yang; Yunkai Yang; Yan Wang
Journal: Clin Epigenetics Date: 2021-05-17 Impact factor: 6.551

3. FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation.

Authors: Ruiqi Zhu; Li Li; Bao Nguyen; Jaesung Seo; Min Wu; Tessa Seale; Mark Levis; Amy Duffield; Yu Hu; Donald Small
Journal: Signal Transduct Target Ther Date: 2021-05-24

Review 4. Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia.

Authors: Bo Yu; Delong Liu
Journal: Biomark Res Date: 2019-10-31

5. 5-aza-2'-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages.

Authors: Rongchen Shi; Kun Zhao; Teng Wang; Jing Yuan; Dapeng Zhang; Wei Xiang; Jin Qian; Na Luo; Yong Zhou; Bo Tang; Chuan Li; Hongming Miao
Journal: Theranostics Date: 2022-01-01 Impact factor: 11.556

6. Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells.

Authors: Jiazhen Wang; Peipei Wang; Tiantian Zhang; Zhuying Gao; Jing Wang; Mengdie Feng; Rong Yin; Haojian Zhang
Journal: Blood Sci Date: 2019-09-17

Review 7. Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Authors: Wei Shi; Weiwei Jin; Linghui Xia; Yu Hu
Journal: Acta Pharm Sin B Date: 2020-06-30 Impact factor: 11.413

8. Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML.

Authors: Ming Hong; Han Zhu; Qian Sun; Yu Zhu; Yi Miao; Hui Yang; Hai-Rong Qiu; Jian-Yong Li; Si-Xuan Qian
Journal: Aging (Albany NY) Date: 2020-04-01 Impact factor: 5.682

9. Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.

Authors: Shujuan Huang; Chenying Li; Xiang Zhang; Jiajia Pan; Fenglin Li; Yunfei Lv; Jingwen Huang; Qing Ling; Wenle Ye; Shihui Mao; Xin Huang; Jie Jin
Journal: Mol Oncol Date: 2020-07-03 Impact factor: 6.603

9 in total